Ok good thanks. Its the bit about RAP that I don't really get (not cross promoting - it's germane to the discussion). At present its a one-off product (albeit aimed at multiple respiratory diseases) which could in effect get taken out post FDA approval early next year. Whereas, I think you are suggesting it could potentially become a platform for delivering a host of tele-health offerings, is that right?
Sorry to labour this...the fog is clearing.
GP LINK, page-10
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
